Vidyadhar M. Paradkar

Author

Ligand Pharmaceuticals (United States)

Also Known As

V. M. PARADKAR, V. M. Paradkar, Vidyadhar M. Paradkar, Vidyadhar Paradkar

Publications

449

Citations

H-Index

Concepts

All Affiliations

Ligand Pharmaceuticals (United States)

About

Vidyadhar M. Paradkar is an author at Ligand Pharmaceuticals (United States) specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	408
2	Biochemistry	8	8	397
3	Natural Sciences	7	7	332
4	Engineering	2	2	34
5	Biomolecular Engineering	2	2	34

Vidyadhar M. Paradkar

Publications

426

Citations

H-Index

Page 1

	Year	Citations
Discovery of Dinaciclib (SCH 727965): A Potent and Selective Inhibitor of Cyclin-Dependent Kinases Kamil Paruch, Michael P. Dwyer, Carmen Álvarez, ACS Medicinal Chemistry Letters Drug TargetPathologyChemical BiologyPharmaceutical ChemistryTumor Biology	2010	174
Design, Synthesis, and Activity of 2-Imidazol-1-ylpyrimidine Derived Inducible Nitric Oxide Synthase Dimerization Inhibitors David D. Davey, Marc Adler, Damian O. Arnaiz, Journal of Medicinal Chemistry Combinatorial ChemistryMedicinal ChemistryBiochemistryNitric OxideDimeric Form	2007	67
Pyrazolo[1,5-a]pyrimidines as orally available inhibitors of cyclin-dependent kinase 2 Kamil Paruch, Michael P. Dwyer, Carmen Álvarez, Bioorganic & Medicinal Chemistry Letters Cyclin-dependent Kinase 2BiochemistryMedicineRational Drug DesignPharmacotherapy	2007	65
Small molecule antagonists of the bradykinin B1 receptor Robert A. Horlick, Michael Ohlmeyer, Ilana L. Stroke, Immunopharmacology Molecular PhysiologyBiochemistryMedicineNatural SciencesReceptor (Biochemistry)	1999	29
2-Benzimidazolyl-9-(chroman-4-yl)-purinone derivatives as JAK3 inhibitors Andrew G. Cole, Adolph C. Bohnstedt, Vidyadhar M. Paradkar, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesMechanism Of Action	2009	18
Oxidative Decarboxylation of α-Amino Acids with in situ Generated Dimethyl Dioxirane Vidyadhar M. Paradkar, Tamara B. Latham, Donald M. Demko Synlett Oxidative DecarboxylationEngineeringAldehyde DehydrogenaseBiochemistryNatural Sciences	1995	18
Conformationally restricted tricyclic antidepressants. 1. Octahydrodibenzazepinonaphthyridines as rigid imipramine analogs Arnold R. Martin, Vidyadhar M. Paradkar, Geoffrey W. Peng, Journal of Medicinal Chemistry EngineeringPsychotropic MedicationAltmetric Attention ScoreOrganic ChemistryPharmacotherapy	1980	16
Conformationally defined adrenergic agents. 8. Synthesis of conformationally defined analogs of norfenfluramine. A highly stereospecific synthesis of amines from alcohols in the benzobicyclo[2.2.1]heptene system Gary L. Grunewald, Vidyadhar M. Paradkar, Bharak Pazhenchevsky, The Journal of Organic Chemistry Molecular PharmacologyStereospecific SynthesisBiochemistryAdrenergic AgentsDonut Icon	1983	15
Novel pyrrolidine heterocycles as CCR1 antagonists J. Robert Merritt, Ray A. James, Vidyadhar M. Paradkar, Bioorganic & Medicinal Chemistry Letters HeterocyclicMedicineNovel Pyrrolidine HeterocyclesHeterocycle ChemistryPharmacology	2010	13
A regioselective synthesis of 8,9-dichloro-2,3,4,5-tetrahydro-1H-2-benzazepine (LY134046), a potent phenylethanolamine N-methyltransferase inhibitor Gary L. Grunewald, Vidyadhar M. Paradkar Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryNatural SciencesMedicineOrganic Chemistry	1991	11

Page 1